CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
27 août 2024 07h00 HE
|
CytoSorbents
PRINCETON, N.J., Aug. 27, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
13 août 2024 16h19 HE
|
CytoSorbents
New CFO Peter J. Mariani to succeed retiring CFO Kathleen P. BlochOn track for DrugSorb™-ATR U.S. FDA De Novo and Health Canada marketing submissions this quarterIn Q2 2024, increased product sales by...
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
13 août 2024 16h18 HE
|
CytoSorbents
PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
CytoSorbents to Report Second Quarter 2024 Operating and Financial Results
07 août 2024 07h00 HE
|
CytoSorbents
CytoSorbents to Report Q2 2024 Financial and Operating Results
CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement
01 août 2024 07h00 HE
|
CytoSorbents
CytoSorbents regains compliance with Nasdaq minimum bid price requirement
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
30 juil. 2024 02h00 HE
|
CytoSorbents
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
29 juil. 2024 08h00 HE
|
CytoSorbents
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
17 juil. 2024 07h00 HE
|
CytoSorbents
CytoSorbents CEO Dr. Phillip Chan to highlight its innovative critical care and cardiac surgery blood purification therapy at AAPI Conference this weekend
CytoSorbents Secures $20 Million Credit Facility
02 juil. 2024 07h00 HE
|
CytoSorbents
$20 million credit facility provides CytoSorbents with important non-dilutive capital to support its regulatory and commercialization objectives
CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan
24 juin 2024 07h00 HE
|
CytoSorbents
Taiwan FDA approval of CytoSorb brings powerful blood purification therapy to critically ill and cardiac surgery patients in the country